The effects of captopril and losartan on erythrocyte membrane Na1+/K1+ - ATPase activity in experimental diabetes mellitus

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 22, Issue 2, 2007, Pages 213-217

  Temel, Halide ^a   Akyuz, Fahrettin ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

ACE; Captopril; Diabetes mellitus; Losartan; Na+ K+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CAPTOPRIL; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DRUG CHOICE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE MEMBRANE; EXPERIMENTAL DIABETES MELLITUS; MALE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTE MEMBRANE; LOSARTAN; MALE; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, WISTAR;

RATTUS;

EID: 34247152957     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360601051324     Document Type: Article

References (38)

1. Parving, HH (1996) Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy. J Diabet Comp, 10:3, pp. 133-135.
2. Vivian, EM and Goebig, LM (2001) Slowing the progression of renal disease in diabetic patients. Ann Pharmacother, 35, pp. 452-463.
3. Ustundag, B., Cay, M., Naziroglu, N., Dilsiz, N., Crabbe, MJC and Ilhan, N. (1999) The study of renin-aldesteron in experimental diabetes mellitus cell. Biochem Funct, 17, pp. 193-198.
4. Szkudelski, T. and Szkudelska, K. (2002) Streptozotocin induces lypolysis in rat adipocytes in vitro. Physiol Res, 51, pp. 255-259.
5. + ATPase, and diabetes. Exp Diab Res, 5, pp. 37-50.
6. + ATPase activities and diabetic complications in patients with type 2 diabetes mellitus. Endocrine, 21:3, pp. 273-278.
7. Murali, B. and Goyal, RK (2001) Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy. Clin Exp Hypertens, 23:7, pp. 513-520.
8. Andersen, S., Tarnow, L., Rossing, P., Hansen, BV and Parving, HH (2000) Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy kidney. Int, 57:2, pp. 601-606.
9. Raccah, D., Fabreguettes, C., Azulay, JP and Vague, P. (1996) Erythrocyte Na/K ATPase activity metabolic control and neuropathy in IDDM patients. Diab Care, 19:6, pp. 564-568.
10. Santoro, R. and De la Riva, IJ (1985) Effect of captopril on Na/ K ATPase and Mg ATPase activity. Pharm Res Commun, 17:4, pp. 323-330.
11. Luheshi, GN and Zar, MA (1991) The effecets of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder. Br J Pharmacol, 193, pp. 265-275.
12. Stevens, EJ, Willars, GB, Lidbury, P., House, F. and Tomlinson, DR (1993) Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: Efect of insulin or aldose reductase inhibition. Br J Pharmacol, 234, pp. 281-285.
13. Kiff, RJ, Gardnier, SM and Compton, AM (1991) The effects of endothelin-1 and NG-nitro-L arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol, 103, pp. 1321-1326.
14. Kiff, RJ, Gardnier, SM, Compton, AM and Bennett, T. (1991) Selective impairment of hindquaters responses to bradykinin in conscious wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol, 103, pp. 1357-1362.
15. Yavuz, DG, Ersöz, O., Kucukkaya, B., Yasemin, B., Ahiskali, R., Ekicioglu, G., Emerk, K. and Akalin, S. (1999) The effect of losartan and captopril on glomerular basement membrane anionic charge in a diabetic rat model. J Hypertens, 17, pp. 1217-1223.
16. Sun, Y., Frederick, AO and Mendelsohn, O. (1991) Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zefenopril, captopril, and lisinopril. J Cardiovasc Pharm, 18:4, pp. 478-486.
17. Kanbak, G., Akyuz, F. and Inal, M. (2001) Preventive effect of betaine on ethanol-induced membrane ATPases. Arch Toxicol, 75, pp. 59-61.
18. Mateucci, C., Cocci, FF, Pellegrini, L., Gregori, G. and Giampietro, O. (1995) Measurement of ATPases in red cells: Setting up and validation of a highly reproduciple method. Enz Protein, 48, pp. 115-119.
19. Holmquist, B., Bunning, P. and Riordan, JF (1987) A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem, 95, pp. 540-545.
20. El-Batran, SA, El-Shenawy, SM, Nofal, SM, Abdel-salam, OM and Arbid, MS (2004) Losartan in normal and diabetic rats. Pharm Res, 50, pp. 131-136.
21. Shionori, H., Lino, S. and Inoue, S. (1987) Glucose metabolism during captopril mono- and combination therapy in dibetic hypertensive patients: A multiclinic trial. Clin Exp Theory Pract, pp. 671-674.
22. Liu, G., Guan, GJ, Qi, TG, Fu, YQ, Sun, Y. and Wen, RZ (2005) Protective effects of Salvia miltiorrhiza on rats with steptozotocin diaebetes and its mechanism. Zhong Xi Yi Jie He Xue Bao, 3:6, pp. 459-462.
23. Katoh, M., Ohmachi, Y., Kurosawa, Y., Yoneda, H., Tanaka, N. and Narita, H. (2000) Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy. Eur J Pharmacol, 398, pp. 381-387.
24. Zandbergen, AA, Baggen, MG, Lamberts, SW, Bootsma, AH, Zeeuw, D. and Ouwendijk, RJ (2003) Effect of losartan on microalbuminurea in normotensive petients type 2 diabetes mellitus. A randomized clinical trial. Ann Intern Med, 139:2, pp. 90-96.
25. Gilbert, RE, Cox, A., Wu, LL, Allen, TJ, Hulthen, UL, Jerums, G. and Coopr, ME (1998) Expression of transforming growth factor-beta 1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition. Diabetes, 47, pp. 414-422.
26. Hostetter, TH (1994) Mechanism of diabetic nephropathy. Am J Kidney Dis, 23:2, pp. 188-192.
27. Renke, M., Tylicki, L., Rutkowski, P., Lysiak-Sydlowska, W. and Rutkowski, B. (2004) Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis. Scand J Urol Nephrol, 38:5, pp. 427-433.
28. Imanishi, M., Yoshioka, K., Okumura, M., Konishi, Y., Tanaka, S., Fujii, S. and Kimura, G. (1997) Mechanism of decrealbuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy. Kidney Int, 52:63, pp. 198-200.
29. Edmund, J., Lawrence, MD and Hunsicker, G. (1993) The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. New Engl J Med, 329:20, pp. 1456-1462.
30. Tylicki, L., Biedunkiewicz, B., Chamienia, A., Wojnarowski, K., Zdrojewski, Z. and Rutkowski, B. (2006) Randomized placebo-controlled study of the effects of losartan and carvedilol on albuminuria in renal transplant recipients. Transplantation, 81, pp. 52-56.
31. Kennefick, TM and Anderson, S. (1997) Role of angiotensin II in diabetic nephropathy. Sem Nephrology, 17:5, pp. 441-447.
32. Leehey, DJ, Singh, AK and Alavi, N. (2000) Role of angiotensin II in diabetic nephropathy Kidney. Int, 58:77, pp. 93-98.
33. Erman, A., Chen-Gal, B. and David, I. (1998) Insulin treatment reduces the increased serum and lung angiotensin-converting enzyme activity in streptozotocin-induced diabetic rats. Scand J Clin Invest, 58, pp. 81-88.
34. Mizuiri, S., Kobayashi, M. and Nakanishi, T. (1997) Renal angiotensin-converting enzyme localization in diabetic rats and the effect of low protein diet. Nephron, 76, pp. 186-191.
35. Prakasam, A., Sethupathy, S. and Pugalendi, KV (2005) Modulating role of Saptarangi esculenta on membrane bound ATPase in sakeptozotocin diabetic rats. Pharmazie, 60:11, pp. 874-877.
36. + ATPase inhibition in experimental diabetes mellitus. Front Biosci, 10, pp. 2257-2262.
37. + ATPase in patients with insulin-dependent diabetes mellitus. Diab Metab, 25:1, pp. 35-42.
38. + ATPase. Clin Physiol Biochem, 7, pp. 101-108.